Cargando…
1q21扩增对硼替佐米治疗初治多发性骨髓瘤患者疗效和预后的影响
OBJECTIVE: To investigate the effect of 1q21 amplification (1q) on the therapeutic response and prognosis of bortezomib(Btz) in the treatment of newly diagnosed multiple myeloma (MM) patients. METHODS: A total of 180 newly diagnosed MM were included for analyses of clinical characteristics, cytogene...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342892/ https://www.ncbi.nlm.nih.gov/pubmed/29779352 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.05.013 |
Ejemplares similares
-
PSMB5对多发性骨髓瘤细胞增殖和硼替佐米耐药的影响及其机制研究
Publicado: (2017) -
国产与原研硼替佐米治疗初诊多发性骨髓瘤的疗效和安全性
Publicado: (2020) -
硼替佐米为基础的化疗序贯自体造血干细胞移植治疗伴1q21扩增初治多发性骨髓瘤患者疗效分析
Publicado: (2018) -
BDDT方案对硼替佐米治疗原发耐药或疗效不佳的多发性骨髓瘤患者的临床疗效分析
Publicado: (2015) -
硼替佐米每周两次与每周一次治疗初诊多发性骨髓瘤的疗效和安全性比较
Publicado: (2017)